Introduction Transcatheter aortic valve implantation (TAVI) is a widely used treatment option
as an alternative to surgical aortic valve replacement in patients with severe aortic stenosis …

Introduction Guidelines recommend aortic valve replacement in patients with severe aortic
stenosis who present with symptoms or left ventricular ejection fraction< 50%, both …

Background—Transcatheter aortic valve replacement (TAVR) has been shown to improve
survival compared with standard therapy in patients with severe aortic stenosis who cannot …

Symptoms of aortic stenosis (AS) are not proportional to its severity and patients with very
severe AS (VSAS) remain asymptomatic for a long time. The appropriate time for …

The objectives of this study were to determine the causes and impact of anemia and
hemoglobin level on functional status, physical performance, and quality of life in the …

Transcatheter aortic valve replacement (TAVR) has been approved in the United States for
intermediate and high-risk patients with severe symptomatic aortic stenosis. More than 80 …

Background Patients with severe aortic stenosis (AS) exhibit systemic endothelial
dysfunction, which can be associated with myocardial ischaemia in absence of obstructive …

Background Gait speed is a reliable measure of physical function and frailty in patients with
aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed …

The recent development of transcatheter aortic valve implantation (TAVI) for severe aortic
stenosis (AS) treatment offers a viable option for high-risk patient categories. Our aim is to …

More than 300,000 patients worldwide have undergone transcatheter aortic valve
replacement (TAVR) for severe aortic stenosis (AS). The rise in TAVR as a treatment option …